on QUANTEL (EPA:QUA)
Promising 2025 half-year results for Lumibird
The Lumibird Group recorded strong growth in the first half of 2025, with EBITDA up 85% to €20.2 million, representing 18.9% of revenue. Overall revenue increased 9.0% to €106.8 million.
In the Medical division, EBITDA increased to €12.1 million, or 21.8% of revenue, thanks to a strengthened sales organization. The Photonics division also experienced growth, with EBITDA of €8.1 million. Growth was particularly strong in Europe in the Defense and Space sectors.
Operating profit increased by 491% to €9.6 million. However, costs related to currency fluctuations impacted the financial result, but net profit stood at €4.9 million.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all QUANTEL news